The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Centre Oscar Lambret
BeOne Medicines
City of Hope Medical Center
Bayer
ViroMissile, Inc.
Arcus Biosciences, Inc.
AstraZeneca
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Pilatus Biosciences Inc
Essen Biotech
Eli Lilly and Company
Brigham and Women's Hospital
Baylor College of Medicine
Jonsson Comprehensive Cancer Center
University of Colorado, Denver
MacroGenics
City of Hope Medical Center
Daiichi Sankyo
Eli Lilly and Company
Boehringer Ingelheim
IDEAYA Biosciences
Second Life Therapeutics
Ocellaris Pharma, Inc.
Medical College of Wisconsin
National Institutes of Health Clinical Center (CC)
Var2 Pharmaceuticals
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University of Pittsburgh
Pfizer
University Health Network, Toronto
Cancer Research UK
NeoTX Therapeutics Ltd.
Tampere University Hospital
BicycleTx Limited
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
Rondo Therapeutics
Actym Therapeutics, Inc.
Institut Bergonié
Day One Biopharmaceuticals, Inc.
Icahn School of Medicine at Mount Sinai
Shanghai Escugen Biotechnology Co., Ltd
Sahlgrenska University Hospital
Washington University School of Medicine
Västernorrland County Council, Sweden
Palleon Pharmaceuticals, Inc.